Antibiotic solutions for every type of operation.
The powerful antibiotic lineup from Merck Animal Health is packed with products that effectively treat Bovine Respiratory Disease (BRD) to help get cattle back where they belong faster.
A tulathromycin option backed by Merck Animal Health.
Now get all the expertise and support of Merck Animal Health plus the benefits of tulathromycin with AROVYN. AROVYN offers veterinarians and producers a new cost-effective option for the treatment and control of respiratory disease from an animal health company you know and trust.
Treats BRD and reduces fever in just one dose.
RESFLOR GOLD combines the powerful antibiotic florfenicol with the fast-acting NSAID flunixin meglumine. It starts controlling the fever associated with BRD in as little as six hours to get cattle back up on their feet.1
The fast-acting, long-lasting BRD treatment.
When BRD takes hold, time is of the essence. That’s why there’s ZUPREVO – the BRD treatment that’s rapidly absorbed in as little as 45 minutes.1 Once in the lungs, it remains there for 28 days.2* Not to mention one low-dose volume of 1 mL/100 lbs. means less handling and more doses per bottle.
Supporting Therapies
Relief is in the palm of your hand.
BANAMINE TRANSDERMAL is the first pour-on approved by the FDA to reduce fever caused by BRD and acute mastitis and pain due to foot rot. It goes to work quickly, and the convenient pour-on administration means less handling, which means less stress on your animals.
Expert tips for battling BRD.
Bovine Respiratory Disease is a complex disease. And the solution isn’t always simple. Listen in as Tim Parks, D.V.M., U.S. Cattle Technical Services Veterinarian for Merck Animal Health discusses key prevention and treatment strategies, the latest technological innovations and more.
All the information, all at your fingertips.
The Merck Feedlot Diseases Atlas app is a thorough collection of information surrounding the diseases that impact feedlot cattle – from the most common ailments to the rarest of conditions. With more than 700 educational, high-resolution images, this app is geared toward veterinary students, clinicians, technicians, cattle producers and more. Watch the video to see how it works.
Browse the complete lineup of Merck Animal Health
antibiotics and supporting therapies.
For treatment of cattle at high risk of developing BRD and the treatment of IBK and bovine foot rot in beef and non-lactating dairy cattle.
Indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis in cattle.
Indicated for the control of fever associated with BRD, bovine mastitis and pain associated with foot rot. The first and only NSAID cattle…
For treatment of BRD associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni, and bovine interdigital phlegmon associated with…
BRD treatment combining two therapies in one dose, a powerful antibiotic florfenicol and a fast-acting NSAID flunixin meglumine to reduce fever.
For the treatment of BRD in cattle, and the control of respiratory disease in cattle at high risk of developing BRD.
Important Safety Information
AROVYN IMPORTANT SAFETY INFORMATION: AROVYN has a pre-slaughter withdrawal time of 18 days in cattle. Do not use in female dairy cattle 20 months of age or older. Do not use in animals known to be hypersensitive to the product. See Full Prescribing Information.
RESFLOR GOLD IMPORTANT SAFETY INFORMATION: Animals intended for human consumption must not be slaughtered within 38 days of treatment. This product is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. For more information, see packaging insert.
ZUPREVO IMPORTANT SAFETY INFORMATION: FOR USE IN ANIMALS ONLY. NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. TO AVOID ACCIDENTAL INJECTION, DO NOT USE IN AUTOMATICALLY POWERED SYRINGES WHICH HAVE NO ADDITIONAL PROTECTION SYSTEM. IN CASE OF HUMAN INJECTION, SEEK MEDICAL ADVICE IMMEDIATELY AND SHOW THE PACKAGE INSERT OR LABEL TO THE PHYSICIAN. RESIDUE WARNING: Cattle intended for human consumption must not be slaughtered within 21 days of the last treatment. Do not use in female dairy cattle 20 months of age or older. Use of this drug product in these cattle may cause milk residue. A withdrawal period has not been established in pre-ruminating calves. Do not use in calves to be processed for veal. The effects of ZUPREVO® 18% on bovine reproductive performance, pregnancy and lactation have not been determined. Swelling and inflammation, which may be severe, may be seen at the injection site after administration. Subcutaneous injection may result in local tissue reactions which persist beyond slaughter withdrawal period. This may result in trim loss of edible tissue at slaughter. DO NOT USE ZUPREVO® 18% IN SWINE. FATAL ADVERSE EVENTS HAVE BEEN REPORTED FOLLOWING THE USE OF TILDIPIROSIN IN SWINE. NOT FOR USE IN CHICKENS OR TURKEYS.
BANAMINE TRANSDERMAL IMPORTANT SAFETY INFORMATION: NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. Milk that has been taken during treatment and for 48 hours after treatment must not be used for human consumption. Cattle must not be slaughtered for human consumption within 8 days of the last treatment. Not for use in replacement dairy heifers 20 months of age or older or dry dairy cows; use in these cattle may cause drug residues in milk and/or calves born to these cows or heifers. Not for use in beef and dairy bulls intended for breeding over 1 year of age, beef calves less than 2 months of age, dairy calves, and veal calves. Do not use within 48 hours of expected parturition. Approved only as a single topical dose in cattle. For complete information on BANAMINE® TRANSDERMAL, see accompanying product package insert.
References
*The correlation between pharmacokinetic data and clinical effectiveness is unknown.
1. Based on label claims.
2. Menge M, et al. Pharmacokinetics of tildipirosin in bovine plasma, lung tissue, and bronchial fluid (from live, non-anesthetized cattle). J Vet Pharm Ther. 2011;1349:1365-2885.
Get the latest updates! Sign up to receive cattle health management insights, industry news and more sent straight to your inbox.